Expanding Cell Therapy Clinical Trials to Community Health Centers: Training Healthcare Providers
Wednesday, May 29, 2024 10:45 AM - 11:45 AM
Room 201
Roundtable
Expanding Cell Therapy Clinical Trials to Community Health Centers: Training Healthcare Providers
Organized by: ISCT Clinical Translation Committee
Moderator
Key Learning Objectives
1. Awareness of current challenges
2. Practical solutions required to enable inexperienced clinical sites to partake in cell therapy clinical trials and administer commercialized products
3. Preparing for CAR-T therapies in becoming SOC
Organized by: ISCT Clinical Translation Committee
Moderator
- Kim Watanabe, PhD, PPD, part of Thermo Fisher Scientific, United States
- Emily Blyth, B.Med (Hons) FRACP, FRCPA, PhD, Westmead Hospital, University of Sydney, Westmead Institute For MedicalAustralia
- Michelle Hermiston, MD, PhD, UCSF, United States
- Shirley Bartido, PhD, MBA, Takeda Development Center Americas, Inc., United States
Key Learning Objectives
1. Awareness of current challenges
2. Practical solutions required to enable inexperienced clinical sites to partake in cell therapy clinical trials and administer commercialized products
3. Preparing for CAR-T therapies in becoming SOC
Kim Watanabe
Executive Director, Cell and Gene Therapy Pillar Head
PPD, Part of Thermo Fisher Scientific
Moderator
Executive Director, Cell and Gene Therapy Pillar Head
PPD, Part of Thermo Fisher Scientific
Moderator
Shirley Bartido
Director, Global Regulatory Affairs Cell Therapy Oncology
Takeda Pharmaceuticals Company Limited
Panelist
Director, Global Regulatory Affairs Cell Therapy Oncology
Takeda Pharmaceuticals Company Limited
Panelist